Jump to content

Dextroamphetamine: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

31 December 2024

28 December 2024

27 December 2024

25 December 2024

21 December 2024

11 December 2024

10 December 2024

9 December 2024

4 December 2024

3 December 2024

29 November 2024

16 November 2024

15 November 2024

14 November 2024

13 November 2024

12 November 2024

11 November 2024

9 November 2024

7 November 2024

3 November 2024

2 November 2024

  • curprev 02:4302:43, 2 November 2024 Slothwizard talk contribs 59,977 bytes −509 Like I said before, using dex for negative symptoms of schizophrenia is not a notable indication and shouldn’t be on lede. There are other more common off-label uses for dex, and they should not be on the lede either. Please go to discussions if there is disagreement, thanks undo Tags: Visual edit Mobile edit Mobile web edit

30 October 2024

25 October 2024

23 October 2024

9 October 2024

1 October 2024

27 September 2024

26 September 2024

  • curprev 23:1723:17, 26 September 2024 Slothwizard talk contribs 59,893 bytes −447 This indication is just from a research paper, this is not an approved nor common off-label use of dex, especially given that it can worsen psychosis. Dextroamphetamine is also off-label antidepressant, but that doesn’t mean we should put that in lede. Also, using it for depression is more common than negative symptoms of schizophrenia by far anyways undo Tags: Visual edit Mobile edit Mobile web edit

22 September 2024

21 September 2024

20 September 2024

19 September 2024

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)